Overview of Dr. Dunkel
Dr. Ira Dunkel is a pediatric hematology and oncology specialist based in New York, NY, with a focus on pediatric neuro-oncology, retinoblastoma, Langerhans cell histiocytosis and pediatric melanoma. He completed his medical education at Duke University School of Medicine, followed by a pediatrics residency at Duke University Hospital and a fellowship in pediatric hematology/oncology at Memorial Sloan Kettering Cancer Center and New York Presbyterian Hospital Weill Cornell. Dr. Dunkel is actively involved in clinical trials, serving as a principal investigator on several studies related to pediatric brain tumors. His professional recognition includes multiple listings as a top doctor by Castle Connolly and New York Magazine.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1989 - 1992
- Duke University HospitalResidency, Pediatrics, 1985 - 1989
- Duke University School of MedicineClass of 1985
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 1989 - 2026
- NJ State Medical License 2022 - 2025
- NC State Medical License 1988 - 1999
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- New York Magazine: Top Doctors Castle Connolly, 2005-2014
- Join now to see all
Clinical Trials
- Chemotherapy in Treating Patients With Retinoblastoma Start of enrollment: 1995 May 01
- High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Start of enrollment: 1997 Sep 01
- Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers Start of enrollment: 1998 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Phase II Study of Responses to Vaccination in Pediatric Cancer Survivors Following Standard-of-Care Non-HSCT Chemotherapy.Sophie Junak, Peter G Steinherz, Tanya Trippett, Julianne Ruggiero, Nicole Zakak
Pediatric Blood & Cancer. 2025-05-01 - 2 citationsEvaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncolo...Michael R Sargen, Raymond L Barnhill, David E Elder, Susan M Swetter, Victor G Prieto
Journal of Clinical Oncology. 2025-03-20 - Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG).Mark M Souweidane, Evan D Bander, Pat Zanzonico, Anne S Reiner, Nicole Manino
Neuro-Oncology. 2025-02-19
Journal Articles
- Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery ChemosurgeryIra J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One
Grant Support
- Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.ST. JUDE CHILDREN'S RESEARCH HOSPITAL1999–2025
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPOLovelace Health Plan PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: